Epigenetic regulation in metabolic diseases: mechanisms and advances in clinical study

YL Wu, ZJ Lin, CC Li, X Lin, SK Shan, B Guo… - … and Targeted Therapy, 2023 - nature.com
Epigenetics regulates gene expression and has been confirmed to play a critical role in a
variety of metabolic diseases, such as diabetes, obesity, non-alcoholic fatty liver disease …

An overview of epigenetics in obesity: the role of lifestyle and therapeutic interventions

AM Mahmoud - International journal of molecular sciences, 2022 - mdpi.com
Obesity has become a global epidemic that has a negative impact on population health and
the economy of nations. Genetic predispositions have been demonstrated to have a …

Targeting the pancreatic β-cell to treat diabetes

A Vetere, A Choudhary, SM Burns… - Nature reviews Drug …, 2014 - nature.com
Diabetes is a leading cause of morbidity and mortality worldwide, and predicted to affect
over 500 million people by 2030. However, this growing burden of disease has not been met …

Dietary factors, epigenetic modifications and obesity outcomes: progresses and perspectives

FI Milagro, ML Mansego, C De Miguel… - Molecular aspects of …, 2013 - Elsevier
Nutritional factors play a life-long role in human health. Indeed, there is growing evidence
that one of the mechanisms by which nutrients and bioactive compounds affect metabolic …

Histone deacetylases as targets for treatment of multiple diseases

J Tang, H Yan, S Zhuang - Clinical science, 2013 - portlandpress.com
HDACs (histone deacetylases) are a group of enzymes that deacetylate histones as well as
non-histone proteins. They are known as modulators of gene transcription and are …

The critical role of epigenetics in systemic lupus erythematosus and autoimmunity

H Long, H Yin, L Wang, ME Gershwin, Q Lu - Journal of autoimmunity, 2016 - Elsevier
One of the major disappointments in human autoimmunity has been the relative failure on
genome-wide association studies to provide “smoking genetic guns” that would explain the …

Epigenetic drug discovery: breaking through the immune barrier

DF Tough, PP Tak, A Tarakhovsky… - Nature reviews Drug …, 2016 - nature.com
Immune-mediated diseases are clinically heterogeneous but they share genetic and
pathogenic mechanisms. These diseases may develop from the interplay of genetic factors …

Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic …

S Khan, GB Jena - Chemico-biological interactions, 2014 - Elsevier
Abstract Type 1 diabetes (T1D) also known as juvenile diabetes is a chronic autoimmune
disorder that precipitates in genetically susceptible individuals by environmental factors …

[HTML][HTML] Epigenetic control of macrophage polarization: implications for targeting tumor-associated macrophages

AE de Groot, KJ Pienta - Oncotarget, 2018 - ncbi.nlm.nih.gov
The progression of cancer is a result of not only the growth of the malignant cells but also the
behavior of other components of the tumor microenvironment (TME). Tumor-associated …

Epigenetic regulation of insulin action and secretion–role in the pathogenesis of type 2 diabetes

C Ling - Journal of internal medicine, 2020 - Wiley Online Library
The prevalence of type 2 diabetes (T2D) is rapidly increasing worldwide. Obesity, physical
inactivity and ageing increase the risk of T2D. Epigenetic modifications can change due to …